Authors: Michelet, C Ruffault, A Sebille, V Arvieux, C Jaccard, P Raffi, F Bazin, C Chapplain, JM Chauvin, JP Dohin, E Cartier, F Bellissant, E

Citation: C. Michelet et al., Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients, ANTIM AG CH, 45(12), 2001, pp. 3393-3402

Authors: Forestier, F de Renty, P Peytavin, G Dohin, E Farinotti, R Mandelbrot, L

Citation: F. Forestier et al., Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model, AM J OBST G, 185(1), 2001, pp. 178-181

Authors: Mouroux, M Yvon-Groussin, A Peytavin, G Delaugerre, C Legrand, M Bossi, P Do, B Trylesinski, A Diquet, B Dohin, E Delfraissy, JF Katlama, C Calvez, V

Citation: M. Mouroux et al., Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial)is not associated with mutations conferring viral resistance, J CLIN MICR, 38(7), 2000, pp. 2726-2730

Authors: Michelet, C Bellissant, E Ruffault, A Arvieux, C Delfraissy, JF Raffi, F Bazin, C Renard, I Sebille, V Chauvin, JP Dohin, E Cartier, F

Citation: C. Michelet et al., Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine, CLIN PHARM, 65(6), 1999, pp. 661-671